ARCHIVES

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

This article is from The Cancer Letter archive.

Vol. 12 No. 34 | August 22, 1986

Download PDF Visit The Full Archive

Related Articles

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

Wender Named ACS Chief Cancer Control Officer

August 9, 2013

In Brief: Kerman New President Of ACCC, David Johnson Names President Elect; Wyder Gets NY Award

March 20, 1981

Kimes, Lenfant, To Retire

July 11, 2003

AACR Academy Names 2014 Class of Fellows

April 4, 2014

Clinical Trials Approved By NCI Last Month

March 29, 2002